The mechanism and cause of motor neuronal cell death in amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disorder, are unknown; gain of function of oligomers and aggregation of misfolded proteins, including carboxyl-terminal fragments (CTFs) of TAR RNA/DNA-binding protein 43 kDa (TDP-43), have been proposed as important causative factors in the onset of ALS. We recently reported that a nuclear localization signal (NLS)-tagged 25-kDa CTF of TDP-43 (TDP25) could decrease the cell-death proportion compared with that promoted by TDP25. Here, we show oligomeric states of NLS-TDP25 and its detailed localization property using super-resolution fluorescence microscopy, FRET, fluorescence recovery after photobleaching, and fluorescence correlation spectroscopy analysis. NLS-TDP25 efficiently formed a nucleolar cap structure via RNA binding in the presence of actinomycin D, but TDP25 did not. Although cytoplasmic inclusion bodies including TDP25 had a disordered and immobile structure, NLS-TDP25 in the nucleolus was ordered and dynamic. In the diffuse state, TDP25 formed fewer oligomers and interacted with the molecular chaperone, HSP70; however, NLS-TDP25 formed oligomers. These results suggested that NLS-tagged TDP25 can change its structure to use ordered oligomeric but nontoxic state. Moreover, the structure of ordered oligomers as well as nuclear sequestration may be important in mediating cytotoxicity in ALS pathology.
Introduction
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by dysfunctional motor neurons and muscle atrophy, inclusion bodies (IBs) containing protein aggregates, and the formation of RNA-protein complexes in the cytoplasm and nucleus of motor neurons (Neumann et al. 2006; Blokhuis et al. 2013) . These IBs are ubiquitin (Ub)-positive and often contain proteins encoded by ALScausative genes, including superoxide dismutase 1 (SOD1), TARDBP (TDP-43), fused in Sarcoma/ translocated in Sarcoma (FUS/TLS), OPTN (Optineurin), among others (Renton et al. 2014) . Typically, ALS-associated proteins are prone to aggregate and use misfolded and/or prion-like properties (Gitler & Shorter 2011) .
TDP-43 is the major disease-associated protein of ALS and frontotemporal lobar degeneration associated with TDP-43 (FTLD-TDP). TDP-43 carries 2 RNA/DNA-recognition motifs (RRM1 and RRM2) and a C-terminal glycine-rich region (GRR) including the prion-like Q/N-rich domain (also known as the low-complexity sequence domain). The consensus RNA/DNA sequence recognized by the RRM is known to be UG/TG repeats (Kuo et al. 2009; Lukavsky et al. 2013) . The GRR mediates interactions with heterogeneous ribonucleoproteins (hnRNPs) (D'Ambrogio et al. 2009 ). TDP-43 harbors a classical nuclear localization signal (NLS) between the N-terminal Ub-like domain and RRM1, as well as a nuclear export signal (NES) in RRM2 (Blokhuis et al. 2013) . Thus, TDP-43 is subject to nuclear-cytoplasmic shuttling and mediates RNA-associated functions, mRNA splicing, microRNA processing and mRNA transport to the cytoplasm. It has been shown that not only intact TDP-43 but also several CTFs of TDP-43 are incorporated into cytoplasmic IBs (Neumann et al. 2006; Fung et al. 2015) . The 25-kDa TDP-43 CTF ) is also known as TDP25 (Zhang et al. 2009 ). TDP25 can be generated by caspase 3-and/or calpain-dependent cleavage of intact TDP-43 (Zhang et al. 2007; Yamashita et al. 2012) . TDP25 lacks an NLS, RRM1 and a portion of RRM2. Therefore, TDP25 does not recognize RNA/DNA that can be recognized by TDP-43 and is distributed in the nucleus and cytoplasm (Kitamura et al. 2016) . TDP25 is prone to aggregation and forming Ub-positive IBs in the cytoplasm. Recently, we reported that NLS-tagged TDP25 (NLS-TDP25) shows less cytotoxicity than TDP25 and does not become incorporated into cytoplasmic IBs (Kitamura et al. 2016) . In addition, cytoplasmic aggregation of a CTF of TDP-43 interferes with nuclear-cytoplasmic transport by altering the subcellular deposition of transport-associated proteins (Woerner et al. 2016) . These findings suggested that the cytoplasmic existence of misfolded aggregation-prone proteins including TDP-43 CTF may lead to neuronal cell death by causing dysfunction in cellular proteostasis.
It is known that cytoplasmic molecular chaperones including heat-shock protein 70, 90 and 40 kDa (HSP70, HSP90 and HSP40, respectively) play a critical role to prevent aggregation of misfolded protein (Morimoto 2008; Brehme et al. 2014) . Induction of these cytoplasmic molecular chaperones in cultured cells by heat shock decreased aggregation of TDP-43 CTFs (Udan-Johns et al. 2014; Chen et al. 2016) . As an inhibitor of HSP70 ATPase activity during inhibition of proteasome activity increased insoluble TDP-43 and its CTF, HSP70 is known as a major contributor to TDP-43 proteostasis (Lin et al. 2016 ).
However, it remains unclear how NLS-TDP25 evades cytoplasmic aggregation and IB formation. It is important to clarify the mechanism of inhibited aggregation, which is involved in neuronal cell death, in order to understand ALS pathophysiology and develop a strategy for curing ALS. Therefore, we analyzed the detailed molecular properties of NLS-TDP25 and TDP25 using multiple biophysical fluorescence spectroscopic techniques, including F€ orster/ fluorescence energy transfer (FRET), fluorescence recovery after photobleaching (FRAP) and fluorescence correlation spectroscopy (FCS).
Results
Nucleolar localization property of TDP25 in inhibiting proteasomal and RNA-transcriptional activity
In cells carrying no cytoplasmic IBs, GFP-tagged TDP25 (G-TDP25) was observed in the cytoplasm and nucleoplasm, but not in the nucleolus (Fig. 1A) . This reduction in nucleolar localization was also seen with TDP-43 tagged with GFP (TDP43-G; Fig. 1A ). In contrast, TDP25 fused to GFP and the SV40 virusderived NLS peptide that can bind to RNA including UG repeat (G-NLS-TDP25) localized into the nucleolus and nucleoplasm (Fig. 1A) , as previously reported (Kitamura et al. 2016) . Localization of G-NLS-TDP25 was enriched in the boundary region between the nucleolus and nucleoplasm (Fig. 1B) . The nucleolar localization property of G-NLS-TDP25 is thought to be involved in the RNA-binding property of the NLS tag, because TDP25 fused to GFP and nucleoplasmin-derived NLS peptide that does not bind to UG-repeat RNA (G-NLS NP -TDP25) was not localized in the nucleolus (Kitamura et al. 2015b (Kitamura et al. , 2016 ; thus, we examined whether the nucleolar localization of G-NLS-TDP25 could be affected by inhibiting RNA transcription using actinomycin D (ActD). After Figure 1 Intracellular localization of TDP25 and NLS-tagged TDP25. (A) Confocal microscopic images of fixed Neuro2A cells expressing TDP43-G, G-TDP25 or G-NLS-TDP25. The nucleolus was stained using propidium iodide (PI). Nuclear DNA was stained using Hoechst 33342. Scale bar = 10 lm. (B) Detailed localization pattern of TDP43-G, G-TDP25 and G-NLS-TDP25 in fixed Neuro2A cells using structured-illumination microscopy (SIM). Scale bar = 5 lm. (C) Subcellular confocal imaging in live Neuro2A cells, with or without treatment with 0.4 lM ActD. Scale bar = 5 lm. The white arrows indicate nucleolar cap-like structures. (D) The proportion of cells containing the nucleolar cap-like structures of TDP43-G and G-NLS-TDP25 (mean AE SD; n = 3). All quantified proportion of cells carrying these structures is represented in Fig. S1 in Supporting Information. (E) Distribution changes of nucleolar G-NLS-TDP25 (green) and R-fibrillarin (red) as nucleolar markers after treatment with 2 lM MG-132 (a proteasome inhibitor) in live Neuro2A cells. Scale bar = 5 lm. (F) The proportion of cells containing nucleolar boundary localization of expressed GFP-tagged protein (mean AE SD; n = 3). ActD treatment, the localization of G-NLS-TDP25 was altered and formed nucleolar cap-like structures and foci in the nucleoplasm. TDP43-G similarly formed nucleolar cap-like structures after ActD treatment (Fig. 1C,D and Fig. S1 in Supporting Information). In contrast, nucleolar cap-like structures of NLS-tagged GFP (G-NLS), which served as a negative control, were not formed after ActD treatment (Fig. 1C,D and Fig. S1 in Supporting Information). In addition, G-TDP25 and G-NLS NP -TDP25 did not form nucleolar cap-like structure after ActD treatment (Fig. 1C,D and Fig. S1 in Supporting Information). This finding suggested that both C-terminal glycinerich region of TDP-43 and UG-repeat RNA-binding property are likely required for the state of nucleolar cap-like structure of TDP-43 during inhibition of RNA transcription.
Next, we observed the localization pattern of G-NLS-TDP25 during the inhibition of proteasome activity as a state of dysregulation of proteostasis and accumulation of misfolded proteins. Interestingly, G-NLS-TDP25 accumulation in the boundary region between the nucleolus and nucleoplasm significantly increased after inhibition of proteasome activity, whereas G-NLS as a tag was not (Fig. 1E,F) . This result may reflect a mechanism of sequestration of an aggregation-prone protein in the nucleolus during the dysregulation of proteostasis.
Exchange dynamics of G-NLS-TDP25 between the nucleolus and nucleoplasm
To determine the exchange rate of G-NLS-TDP25 between the nucleolus and nucleoplasm, we carried out FRAP analysis of G-NLS-TDP25 ( Fig. 2A) . The fluorescence-recovery proportion of G-NLS-TDP25 in the nucleolus was 53.6% without proteasome inhibition, but proteasome inhibition significantly decreased in the mobile fraction (to 8.9%; Fig. 2A ). G-NLS in the nucleolus (measured as a control) showed rapid recovery and more than 97% mobility, both with and without proteasome inhibition (Fig. 2B) . The 53.6% mobility of G-NLS-TDP25 in the nucleolus without proteasome inhibition strongly contrasted with the previously shown 11% mobility of G-TDP25 in cytoplasmic IBs (Kitamura et al. 2016) . The increased immobility and efficient formation of nucleolar boundary structure of NLS-TDP25 in presence of MG-132 suggested that nucleolar accumulation of G-NLS-TDP25 may not involve sequestration by other proteins, but may be due to a signal promoting the nucleolar retention of G-NLS-TDP25 that shows increased activity during proteasome inhibition.
Distinct intermolecular orientation of NLS-TDP25
Next, we investigated how NLS-TDP25 accumulated in the nucleolus. To compare the intermolecular orientation of TDP25 in cytoplasmic IBs and during nucleolar accumulation, we carried out intermolecular FRET analysis between TDP25 or NLS-TDP25 N-terminally fused to monomeric super-enhanced cyan fluorescent protein (mSECFP) as a donor and a monomeric and bright variant of yellow fluorescent protein (mVenus) as an acceptor. We recently reported that the intermolecular orientation of an aggregation-prone protein in IBs could be determined by comparing the FRET efficiency between a conventional fluorescent protein and a circular permutant (CP) as an acceptor (Kitamura et al. 2014 (Kitamura et al. , 2015a . Thus, we used a CP variant of mVenus (cp173mVenus) in this study. In cytoplasmic IBs, the FRET efficiency of TDP25 was not affected by changing the orientation of the acceptor (Fig. 3A , lanes 1 and 2), indicating that TDP25 is present in accumulated cytoplasmic IBs in an angle-independent orientation in an amorphous state. In contrast, the FRET efficiency of NLS-TDP25 in the nucleolus was significantly changed by introduction of the tagged CP variant (48% and 33%; Fig. 3A , lanes 3 and 4, respectively) and was significantly higher than that of a non-FRET control (5.0% and 1.8%; Fig. 3A , lanes 5 and 6, respectively). Next, to check a different conformation of TDP-25 itself rather than an effect of NLS, we further analyzed intermolecular FRET of NLS-TDP25 fused to C-terminal fluorescent tags; and the FRET efficiency was significantly affected by changing the orientation of the acceptor (4.1% and 9.9%; Fig. 3B ). These findings indicated that the intermolecular orientation of NLS-TDP25 in the nucleolus was ordered and completely different from that of TDP25 in the cytoplasmic IBs. Next, we analyzed the FRET efficiency of a non-IB-forming region of TDP25 in the nucleoplasm and cytoplasm (Fig. 3C , lanes 1-4). Positive FRET efficiency of TDP25 in the cytoplasm and nucleoplasm was not observed, either in the presence or in the absence of the tagged CP (Fig. 3C, lanes 1-4) . In contrast, nucleoplasmic NLS-TDP25 showed weak but significantly positive FRET efficiency compared to that observed with co-expression of a monomeric donor and acceptor as a negative control (Fig. 3C , lanes 5 and 6), suggesting that a portion of NLS-TDP25 may form oligomers in the nucleoplasm. These results suggested that the intermolecular orientation of NLS-TDP25 was completely different from that of TDP25.
Molecular diffusion dynamics of TDP25 and NLS-TDP25
Next, to analyze whether the negative FRET efficiency of TDP25 in the nucleoplasm and the cytoplasm reflected reduced oligomerization, we analyzed the diffusion state of G-TDP25 in live cells using FCS, which can detect molecular dynamics and oligomeric states with single-molecule sensitivity (Rigler et al. 1993; Kitamura et al. 2006 Kitamura et al. , 2015b . G-TDP25 and G-NLS-TDP25 were slowly diffuse compare with monomeric GFP in the live cells ( Fig. S2 in Supporting Information). We carried out curve-fitting analysis using a 1-or 2-component diffusion model for GFP in the nucleolus or others, respectively. Fitting with the 2-component diffusion model for GFP in the nucleolus did not show slow component; thus, diffusion coefficient of GFP in the nucleolus obtained from fitting with the 1-component model was categorized as the fast diffusion. The fastdiffusion coefficients (D Fast ) of G-TDP25, G-NLS-TDP25 and G-NLS in the nucleoplasm or cytoplasm were significantly smaller than those of GFP in the same compartments, which were studied as controls The estimated molecular weights from the D Fast values for G-TDP25 and G-NLS-TDP25 were 100-200 kDa, indicating that G-TDP25 and G-NLS-TDP25 were not present as monomers in the cytoplasm and nucleoplasm (Fig. 4A) . Although the D Fast of G-NLS-TDP25 in the nucleoplasm (17.2 AE 7.61 lm 2 /s) was not different from that of the G-NLS control (23.7 AE 12.9 lm 2 /s), the slowdiffusion coefficient (D Slow ) of G-NLS-TDP25 in the nucleoplasm (0.943 AE 0.537 lm 2 /s) was significantly smaller than that of G-NLS (2.75 AE 2.36 lm 2 /s; Fig. 4B ), indicating that the molecular weight of slowly diffusing complexes including G-NLS-TDP25 was higher than those including G-NLS. The slowly diffuse component of G-TDP25 in any compartments and G-NLS-TDP25 in the nucleoplasm increased significantly compared to that of GFP (Fig. 4C) . These results suggested that G-TDP25 and G-NLS-TDP25 formed oligomers and/or complexes with endogenous proteins in the live cells, but unfortunately, we did not distinguish diffusion property between G-TDP25 and G-NLS-TDP25. Next, we analyzed the counts per molecule (CPM) value, which indicates molecular fluorescence brightness per single particle measured by FCS analysis, detecting homo-oligomerization of fluorescent molecules. The CPM values of both G-TDP25 and G-NLS-TDP25 were smaller than those of the GFP control, suggesting that their fluorescence-emission efficiencies were likely lower than those of monomeric GFP in live cells (Fig. 4D) ; therefore, we could not directly investigate the existence of homo-oligomers of G-TDP25 and G-NLS-TDP25 using the CPM analysis. However, the intermolecular FRET efficiency of NLS-TDP25 was positive in the nucleoplasm (Fig. 3B) ; therefore, at least NLS-TDP25 forms homo-oligomers in the nucleoplasm, whereas TDP25 forms high molecular weight complex with endogenous partner proteins likely rather than homo-oligomers.
Although both the D Fast and D Slow values of G-TDP25 in the nucleolus were not different from those in the cytoplasm and nucleoplasm, the fraction of slow component increased compared to that in the cytoplasm and nucleoplasm (Fig. 4C ), indicating that a portion of G-TDP25 can localize to the nucleolus and diffuses slowly.
Our FRET and FCS analyses showed that NLS-TDP25 forms oligomers and diffuses in the nucleoplasm, whereas TDP25 also diffuses in the nucleoplasm, but forms fewer oligomers. The oligomerization of NLS-TDP25 may serve an important role in preventing the transmission of aggregation and may be involved in inhibiting the formation of cytoplasmic IBs.
TDP25 and NLS-TDP25 binds to the molecular chaperone, HSP70
To identify endogenous interacting partner proteins with TDP25, we carried out IP of G-TDP25 followed by MS. After IP of G-TDP25 using an anti-GFP antibody, several G-TDP25-specific bands were obtained (Fig. 5A ). The bands (ii) and (iii) of Fig. 5A were determined to be peptides in TDP-43 by MS. Thus, these bands (ii & iii) were G-TDP25. Band (i) was identified as heat-shock protein family A member 8 (HSPA8), a cognate type of HSP70, which is a cytoplasmic and nuclear molecular chaperone carrying a substrate-release function in the presence of adenosine triphosphate (ATP) (Morimoto 2008; Kampinga & Craig 2010; Hartl et al. 2011) . Band (iv) in the negative-control GFP lane was detected as GFP. These results indicated that HSP70 was specifically coprecipitated with G-TDP25.
Next, to confirm the interaction between G-TDP25 and HSP70 in a soluble state, we carried out fluorescence cross-correlation spectroscopy (FCCS) analysis, which can detect interactions between 2-color fluorescent molecules in solution with singlemolecule sensitivity (Bacia et al. 2006; Kitamura et al. 2016) . A positive and high amplitude of the crosscorrelation function (CCF) was found between G-TDP25 and RFP-tagged HSP70 (HSP70-R) in the cell lysate (blue line in Fig. 5B ). In contrast, addition of magnesium ion and ATP to the cell lysate decreased the CCF amplitude (magenta line in Fig. 5B ). Moreover, weaker CCF amplitudes between GFP and RFP as a negative control were observed in the presence or absence of magnesium ion and ATP (orange and green lines in Fig. 5B ). These results indicated that HSP70 may transiently bind to TDP25 with its ATPase cycle.
Next, to compare HSP70-interaction state between TDP25 and NLS-TDP25, we carried out immunoprecipitation followed by Western blotting. Lysates of Neuro2A cells expressing GFP, G-NLS, G-TDP25 or G-NLS-TDP25 were prepared, and immunoprecipitation was carried out using anti-GFP antibody-conjugated beads. Endogenous HSPA8 was coprecipitated with G-TDP25 and G-NLS-TDP25, but not with GFP and G-NLS as tags (Fig. 5C ). The band intensity of coprecipitated HSPA8 with G-NLS-TDP25 was not changed compared to that with G-TDP25, suggesting that both G-TDP25 and G-NLS-TDP25 in a soluble state are likely recognized by HSP70 at a similar level (Fig. 5C, lanes 3 & 4) .
Next, confocal fluorescence microscopy showed that fluorescence intensity of HSP70-R in a cytoplasmic inclusion body of G-TDP25 was high, whereas that of HSP70-R in the nucleolus accumulating G-NLS-TDP25 was low (Fig. 5D) . The colocalization of RFP as a tag with G-TDP25 in the cytoplasmic inclusion body and with G-NLS-TDP25 in the nucleolus was not observed (Fig. 5D ). In addition, HSP70-R and RFP were not accumulated in the nucleolus in cells expressing TDP43-G, G-NLS and GFP ( Fig. 5D and Fig. S3 in Supporting Information). It was suggested that HSP70 can bind to both TDP25 and NLS-TDP25; however, HSP70 may strongly bind to disordered aggregation of TDP25. As HSP70 is known as a molecular chaperone recognizing denatured substrates preferentially, these results suggested that HSP70 interacted to G-TDP25 and NLS-TDP25 likely due to protect aggregation formation.
Discussion
Our findings suggested that the aggregation-prone protein TDP25 tagged with NLS (NLS-TDP25) can be sequestrated into the nucleolus (Fig. 1) . Recently, the intranuclear quality control compartment that exists around the nucleolus was identified in Saccharomyces cerevisiae (Miller et al. 2015) . The nucleolus and border region with the nucleoplasm may be able to sequestrate toxic aggregation-prone proteins and Figure 4 Molecular dynamics of TDP25 and NLS-TDP25 in live Neuro2A cells, as determined using FCS. Fast/slow-diffusion coefficients (A,B), fast/slow components (C) and counts per molecule (CPM; D) were obtained for 1-or 2-component curve-fitting analysis for GFP in the nucleolus or others, respectively. Student's t-test: # P < 0.05, ## P < 0.01 and ### P < 0.001 indicate significant differences compared to GFP in the same subcellular compartment; *P < 0.05 and ***P < 0.001 indicate significant differences between two groups. prevent cellular toxicity during proteostasis dysregulation. Although penetration of TDP25 lacing NLS into the nucleolus is negatively regulated in the absence of cellular stress, a low amount of TDP25 can exist and diffuse into the nucleolus (Figs 1,4) .
The nucleolus is known to be an important site for RNA biogenesis and performs important functions in cellular stress responses (Boulon et al. 2010; Audas et al. 2012) . ActD treatment dramatically changes the environment of the nucleolus (Reynolds et al. 1964) . Genes to Cells (2017) 22, 521-534 In this study, ActD induced nucleolar cap-like structures with G-NLS-TDP25 and TDP43-G, but not with G-TDP25 and G-NLS NP -TDP25 (Fig. 1C) . TDP-43 and G-NLS-TDP25 recognize and bind to RNA containing UG repeats, whereas G-TDP25 and G-NLS NP -TDP25 cannot (Kitamura et al. 2016) . Therefore, formation of the nucleolar cap-like structure of TDP-43 and NLS-TDP25 may be involved in both RNA binding and the C-terminus of TDP-43 including glycine-rich region.
We recently reported that G-NLS-TDP25 can reduce cytotoxicity and the formation of cytoplasmic IBs. An important question is what is necessary to reduce the toxicity resulting from aggregationprone TDP25. Our IP-MS and FCCS analyses showed that TDP25 interacts to HSP70, a molecular chaperone in the cytoplasm and nucleus. HSP70 prevents the aggregation of misfolded proteins and is involved in IB sequestration of aggregation-prone proteins (Muchowski et al. 2000; Morimoto 2008; Kampinga & Craig 2010) . Heat-shock responseinduced expression of heat-shock proteins (e.g., HSP70, HSP90 and HSP40) plays a protective role for aggregation of TDP-43 (Chen et al. 2016; Lin et al. 2016) . In particular, an inhibitor of HSP70 ATPase activity increases insoluble amount of TDP-43 and its CTF (Udan-Johns et al. 2014) . Although the interaction between HSP70 and TDP25 has been previously reported using immunoprecipitation study (Zhang et al. 2010) , our FCCS results directly confirmed that the specific interaction between TDP25 and HSP70 in solution occurred in an Mg 2+ /ATP-dependent manner. The observation of HSP70 binding suggested that TDP25 exists in a misfolded state, and HSP70 chaperone cycle may play an important role for transient binding to TDP25 in cells. Moreover, coprecipitated amount of HSP70 with NLS-TDP25 was not different from that with TDP25, suggesting that HSP70 can recognize both TDP25 and NLS-TDP25 in a diluted Mg 2+ /ATP concentration. However, NLS-TDP25 in the nucleolus was weakly colocalized with HSP70 (Fig. 5) . We thus suggested that HSP70 may recognize the different misfolded state of TDP25.
NLS-TDP25 oligomers may result in less cytoplasmic IB formation, in addition to nuclear retention via the NLS (Fig. 6) . Our biophysical FRET and FRAP analyses showed that NLS-TDP25 formed dynamic and ordered assemblies in the nucleolus, whereas the assembly state of TDP25 in the cytoplasmic IBs was disordered and immobile (Figs 2,3) . We recently reported that NLS-TDP25 binds to RNA containing UG repeat. The dynamic accumulation of NLS-TDP25 in the nucleolus may result from RNA binding. Poly-dipeptide sequences encoded by the ALS-associated C9orf72 repeats bind to the nucleolus and impede RNA biogenesis (Kwon et al. 2014) . Thus, nucleolar localization of aggregation-prone proteins is not likely to be a cure-all for preventing cytotoxicity. We also recently reported that non-RNA-binding NLS NP -tagged TDP25 showed less nucleolar localization but lower toxicity in the cells (Kitamura et al. 2016) . Consequently, nucleoplasmic sequestration of TDP25 may be important in reducing cytotoxicity due to its role in reducing the cytoplasmic concentrations of toxic species, and the underlying mechanism(s) of toxicity and details of the associated quality control mechanism for misfolded proteins should be investigated.
The estimated molecular weight of TDP25 from the D Fast value in live cells was 103 and 186 kDa in the nucleoplasm and cytoplasm, respectively, which both exceed the molecular weight limit for passive diffusion through the nuclear pore complex (~50 kDa) (Mattaj & Englmeier 1998) . A possible explanation of the nuclear localization mechanism of TDP25 lacking a classical NLS is that TDP25 can bind to endogenous NLS-carrying proteins, and/or TDP25 may include a nonclassical NLS sequence such as the acidic M9 domain of hnRNP A1 (Siomi & Dreyfuss 1995) . To prevent the cytoplasm-associated cytotoxicity of TDP25, the mechanism of nuclear localization of TDP25 should be clarified.
We concluded that cytoplasmic localization of nonordered aggregation including TDP25 may be an important role to exert toxicity; therefore, the discovery of drugs that can avoid cytoplasmic localization and stabilize the structure of nontoxic oligomers, such as NLS-tagged TDP25, should be important for the prevention and cure of ALS.
Experimental procedures

Plasmids and reagents
Plasmids for GFP-tagged TDP-43, TDP25, NLS-TDP25 and NLS NP -TDP25 (TDP43-G, G-TDP25, G-NLS-TDP25 and G-NLS NP -TDP25, respectively) expressions were described previously (Kitamura et al. 2016) . NLS NP means nucleoplasmin-derived NLS sequence. GFP tag was fused at N-terminus of TDP25 and NLS-TDP25, while that was fused at C-terminus of TDP-43. For FRET analysis, cDNA fragment of C-terminally fluorescent protein-tagged NLS-TDP25 was created using PCR and followed by subcloned into pcDNA3.1(+) (Thermo Fisher Scientific, Waltham, MA, USA). Construction of NLS-tagged GFP and mCherry-tagged fibrillarin (G-NLS and R-fibrillarin, respectively) was described previously (Kitamura et al. 2015b). The HSP70 sequence in a plasmid encoding HSP70-GFP (peGFP-N1-HSP70; kindly provided from Prof. H. Kubota in Akita Univ., Akita, Japan) was subcloned into pmCherry-N1 (HSP70-R). MG-132 and actinomycin D (ActD) were purchased from Peptide Institute (Osaka, Japan) and Sigma-Aldrich (St. Louis, MO, USA), respectively.
Cell culture and transfection
Mouse neuroblastoma Neuro2A cells were maintained at 37°C and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM; #D5796; Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; GE Healthcare, Logan, UT, USA), 100 U/mL penicillin G (Sigma-Aldrich) and 100 lg/mL streptomycin (Sigma-Aldrich). Lipofectamine 2000 (Thermo Fisher Scientific) was used for transfections, as described previously (Kitamura et al. 2015b (Kitamura et al. , 2016 .
Confocal fluorescence microscopy
Confocal fluorescence microscopy images were acquired on an LSM 510 META system through a C-Apochromat 409/1.2NA Korr. UV-VIS-IR water-immersion objective (Carl Zeiss, Jena, Germany). GFP was excited at 488 nm. GFP fluorescence was collected through a band-pass filter (BP505-530). Pinhole sizes were set to 72 lm. The zoom factor was set to 49. The X-and Y-scanning sizes were each 512 pixels. Colocalization images between G-NLS-TDP25 and R-fibrillarin were acquired as previously reported (Kitamura et al. 2015b) . Figure 6 Model of formation of toxic-or nontoxic TDP25 aggregates/oligomers. A putative comparison of the mechanisms of oligomerization of NLS-TDP25 and TDP25. A putative structure of TDP25 was used, based on results from a previous study (Kitamura et al. 2016) . TDP25 aggregate formation is protected by interactions with RNA (green) (Kitamura et al. 2016) . The NLS tag binds to nucleolar RNA (orange) (Kitamura et al. 2015b) . Intermolecular assembly of NLS-TDP25 via nucleolar RNA may form differently ordered oligomers (bottom left). In contrast, TDP25 lacking complexed RNA immediately forms cytoplasmic aggregates (bottom right).
Genes to Cells (2017) 22, 521-534 Immunofluorescence staining and superresolution microscopy Cells were cultivated on cover slips (0.15-0.18 mm, Matsunami, Osaka, Japan). Transfection was carried out using Lipofectamine 2000 (Thermo Fisher Scientific) as described previously (Kitamura et al. 2015b) . Cells were fixed with 4% paraformaldehyde buffered with HEPES-KOH (pH 7.5) at 37°C. The cells were washed in TBS and permeabilized in the presence of 0.5% (v/v) Triton X-100 (Nacalai Tesque, Kyoto, Japan) and 0.5% (w/v) saponin (Sigma-Aldrich). After blocking nonspecific binding activity in a blocking buffer containing 5% normal goat serum (DAKO, Glostrup, Denmark) and 20% glycerol in PBS, the cells were incubated for 1 h at room temperature in blocking buffer containing a primary antibody against enhanced GFP (EGFP) conjugated with Alexa Fluor 488 (#D153-A48; MBL, Nagoya, Japan), 1.0 lg/mL propidium iodide (PI; Thermo Fisher Scientific) for nucleolar staining and 1.0 lg/mL Hoechst 33342 (Sigma-Aldrich) for nucleoplasmic staining. Cells stained on cover slips were mounted with ProLong Gold (Thermo Fisher Scientific). For confocal fluorescence microscopy, images were acquired on an LSM 510 META system through a C-Apochromat 409/1.2NA Korr. UV-VIS-IR water-immersion objective (Carl Zeiss). Colocalization images in Fig. 1A were acquired as previously reported (Kitamura et al. 2015b) . For super-resolution SIM, images were acquired on an N-SIM system (Nikon, Tokyo, Japan) equipped with an Apo TIRF 1009/1.49 NA oil-immersion objective (Nikon). Alexa Fluor 488 was excited at 488 nm. Image acquisition and SIM reconstruction were operated on an NIS-elements software platform (Nikon).
FRAP
Photobleaching experiments were carried out on an LSM 510 META system through a C-Apochromat 409/1.2NA W Korr. UV-VIS-IR objective (Carl Zeiss). GFP was excited and photobleached at 488 nm. GFP fluorescence was collected through a band-pass filter (BP505-550). The pinhole size was set to 72 lm, the zoom factor was set to 59, and the interval time for image acquisition was set to 10 s. The X-and Y-scanning sizes were each 512 pixels. The photobleaching period was 1.3 s. Relative fluorescence intensity (RFI) was measured using AIM3.2 software (Carl Zeiss) and calculated according to Eqn 1. 
where I(t) is the intensity at time point t, I 0 is the base line intensity, A is the maximum recovery rate, and k is recovery constant.
Acceptor photobleaching for FRET analysis
Neuro2A cells were grown in a 35-mm glass-bottom dish (#3910-035, Asahi-Technoglass, Shizuoka, Japan) for 16 h before the transfection. A plasmid mixture consisting of 300 ng of the plasmid encoding a donor protein (monomeric super-enhanced cyan fluorescent protein; mSECFP) and 700 ng of the plasmid encoding the acceptor (mVenus or cp173mVenus) was transfected into Neuro2A cells with 2.5 lL of Lipofectamine 2000. Confocal fluorescence microscopy analysis for acceptor photobleaching was carried out on an LSM 510 META through a C-Apochromat 409/1.2NA W Korr. UV-VIS-IR objective (Carl Zeiss) at 37°C and 5% CO 2 . The microscope was operated on the AIM 4.2 software platform (Carl Zeiss). mSECFP and mVenus were excited at 458 or 514 nm, respectively. The excitation beams were split by an HFT458/514 filter. CFP and Venus fluorescent signals were collected through a spectrophotometer at 477-509 and 531-649 nm, respectively. The pinhole size was set to 67 lm, the zoom factor was set to 59, and the X-and Y-scanning sizes were 256 pixels each. The images were reconstructed using the average values from 4-line scanning. The image acquisition and the photobleaching periods were alternately repeated until the disappearance of acceptor fluorescence. The FRET efficiency (E FRET ) was calculated using Eqn 3.
where I DA and I D indicate the fluorescence intensity before and after acceptor photobleaching, respectively.
FCS
Neuro2A cells were cultured in 3.5-cm plastic dishes (Thermo Fisher Scientific) for 16 h before transfection. For expression of GFP, GFP-TDP25, GFP-NLS and GFP-NLS-TDP25, the amount of plasmid DNA used was 200, 1000, 100 and 1000 ng, respectively. The pCAGGS plasmid was added as necessary to increase the total amount of plasmid DNA to 1.0 lg. At 24 h after transfection with Lipofectamine 2000, the culture medium was replaced, and then, FCS measurements were taken. FCS measurements were taken on an LSM 510 META equipped with ConfoCor 3 system and a CApochromat 409/1.2NA UV-VIS-IR Korr. water-immersion objective (Carl Zeiss), as described previously (Kitamura et al. 2015b) . GFP was excited at 488 nm. The confocal pinhole diameter was adjusted to 70 lm. Emission signals were detected through a 505-nm long-pass filter. The fluorescence autocorrelation function, G(s), from which the time (s) and the absolute amount of fluorescent proteins in the detection volume were calculated, was calculated according to Eqn 4:
where I(t + s) is the fluorescence intensity obtained by the single-photon counting method in a detection volume at delay time s (angular brackets denote ensemble averages). A multicomponent diffusion model with a triplet state for curve fitting is given by Eqn 5:
where F i and s i are the fraction and diffusion time of component i, respectively; N is the average number of fluorescent molecules in the analyzed volume defined by the beam waist w 0 and the axial radius z 0 ; s is the structure parameter representing the ratio of w 0 to z 0 ; m is the number of components (m = 1 or 2); T is the triplet fraction; and s triplet is the relaxation time of the triplet state. G(s) values were measured for 35 s at 37°C. After pinhole adjustment, the diffusion time and structure parameter were determined using a 10 À7 M rhodamine 6G (Rh6G) solution as a standard before measurements. The diffusion coefficients of fluorescent molecules (D sample ) were calculated from the published diffusion coefficient of Rh6G, D Rh6G (414 lm 2 /s) and the measured diffusion periods of Rh6G under condition (s Rh6G ) and with probe proteins (s sample ), according to Eqn 6:
To calculate the molecular weight, we used Eqn 7 and the diffusion coefficient of GFP in the same subcellular compartment as a standard (Kitamura et al. 2015b (Kitamura et al. , 2016 ,
Normalized G C (s) was calculated using Eqn 9.
Normalized G C ðsÞ ¼
where G C (s) and G R (0) are the cross-correlation function and autocorrelation function of RFP at delay time zero.
Western blotting
The immunoprecipitated samples according to the procedure during IP-MS analysis were applied to a 10%-20% e-PAGEL (#2331740; ATTO, Tokyo, Japan) and subjected to electrophoresis in SDS-containing buffer. The proteins were blotted on a polyvinylidene difluoride (PVDF) membrane (GE Healthcare) using a mini-trans blot cell (Bio-Rad, Hercules, CA, USA). The membranes were blocked in 5% skim milk in PBS-T (PBS containing 0.05% Tween-20). After the membranes were washed in PBS-T 3 times, a primary mouse monoclonal anti-GFP antibody (GF200; Nacalai Tesque, Kyoto, Japan), rabbit monoclonal anti-HSPA8 (#EP1531Y; Abcam, Cambridge, UK) or mouse monoclonal anti-GAPDH (#6C5; HyTest, Turku, Finland) was allowed to react with the membrane in the blocking buffer or Can Get Signal Solution 1 (TOYOBO, Osaka, Japan). As secondary antibodies, antimouse or rabbit IgG antibody conjugated with horseradish peroxidase (The Jackson Laboratory, Bar Harbor, ME, USA) was incubated with the membranes in the blocking solution.
Images of the luminescent signals were acquired on a LAS 4000 mini (Fujifilm, Tokyo, Japan) with an ECL reagent (GE Healthcare). The images were processed in the IMAGEJ 1.50i software (National Institutes of Health, Bethesda, MD, USA) and PHOTOSHOP CS4 software (Adobe Systems, San Jose, CA, USA).
Generation of graphs and statistics
Student's t-test was carried out in Microsoft Excel 2013 or 2015 to determine statistical significances. Graphs were drawn using Origin 2016 (Origin Lab. Corp.).
